Share Price and Basic Stock Data
Last Updated: November 19, 2025, 8:47 pm
| PEG Ratio | 21.64 |
|---|
Analyst Insight & Comprehensive Analysis
Business Overview and Revenue Trends
Chembond Chemicals Ltd operates within the specialty chemicals sector, focusing on producing a diverse range of chemical products. As of the latest financial year ending March 2025, the company reported sales of ₹201 Cr, reflecting a notable increase from ₹178 Cr in the previous financial year. This upward trend in revenue is consistent with the company’s quarterly sales figures, where it recorded ₹122.03 Cr in March 2023 and ₹113.54 Cr in June 2023, although a decline was noted in subsequent quarters, with sales dropping to ₹47.09 Cr in March 2024. The sales trajectory indicates that despite short-term fluctuations, Chembond has maintained a growing overall revenue stream, showing resilience in a competitive market environment. The company’s sales performance remains a critical indicator of its operational efficiency and market demand for its products, which are essential for various industrial applications.
Profitability and Efficiency Metrics
Chembond Chemicals has demonstrated varying profitability metrics over recent financial periods. The operating profit margin (OPM) stood at 6.02% as of March 2025, a decline from previous highs of 10.83% in March 2023. The net profit for the same period was reported at ₹18 Cr, which is an increase from ₹11 Cr in March 2024. However, the company faced significant tax rates, with the tax percentage hitting 25.22% in March 2025. Meanwhile, the interest coverage ratio (ICR) was exceptionally high at 71.55x, signaling a strong ability to cover interest expenses, which was only ₹1 Cr in the latest year. The return on equity (ROE) was reported at 10.5%, and return on capital employed (ROCE) at 11.5%, indicating efficient use of capital to generate profits, although these figures suggest room for improvement compared to industry benchmarks.
Balance Sheet Strength and Financial Ratios
Chembond Chemicals maintains a robust balance sheet with total assets reported at ₹202 Cr as of March 2025. The company’s reserves increased to ₹149 Cr, up from ₹137 Cr in March 2024, reflecting a solid retention of earnings. Borrowings remain low at ₹3 Cr, indicating a conservative approach to debt management and financial leverage, which is a significant strength in ensuring financial stability. The current ratio stood at 4.81, well above the typical industry benchmark of 1.5, suggesting strong liquidity and a solid ability to meet short-term obligations. However, the company’s book value per share increased to ₹64.77, indicating a healthy net asset position. Yet, the absence of a price-to-book value (P/BV) ratio due to the lack of market value can be seen as a limitation, as it restricts comprehensive valuation assessments.
Shareholding Pattern and Investor Confidence
Chembond Chemicals exhibits a stable shareholding pattern, with promoters holding a significant 67.65% stake. This high level of promoter ownership often translates into strong management confidence and alignment with shareholder interests. Foreign institutional investors (FIIs) hold a modest 0.61%, while domestic institutional investors (DIIs) account for 0.74%. The public shareholding stands at 31%, indicating a reasonable distribution of shares among retail investors. The number of shareholders increased to 13,168 as of September 2025, up from 12,979 in March 2025, reflecting growing investor interest. However, the low participation from FIIs could suggest limited confidence in the stock from international investors, which may affect liquidity and market perception. Overall, the stable promoter holding coupled with a growing number of shareholders suggests a solid foundation for investor confidence.
Outlook, Risks, and Final Insight
The outlook for Chembond Chemicals is cautiously optimistic, given its consistent revenue growth and strong balance sheet position. However, potential risks remain, including fluctuations in raw material costs and ongoing volatility in sales, as evidenced by the drop in quarterly revenues following a peak in March 2023. Additionally, the high tax rates could impact net profitability moving forward. Strengths such as a low debt level and high interest coverage provide a buffer against financial distress. Furthermore, effective management of operational costs will be crucial for improving margins in a competitive market. In scenarios where the company can stabilize its sales and enhance operational efficiency, it could see improved profitability and shareholder returns. Conversely, if market conditions worsen or cost pressures increase, profitability could be adversely affected.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of Chembond Chemicals Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| HP Adhesives Ltd | 426 Cr. | 46.9 | 86.7/42.6 | 26.5 | 20.5 | 0.85 % | 13.6 % | 9.82 % | 2.00 |
| Haryana Leather Chemicals Ltd | 36.0 Cr. | 73.4 | 103/56.0 | 17.2 | 89.6 | 1.36 % | 8.02 % | 5.45 % | 10.0 |
| Hardcastle & Waud Mfg Co Ltd | 46.7 Cr. | 687 | 988/600 | 21.5 | 697 | 0.00 % | 6.31 % | 2.91 % | 10.0 |
| Grauer & Weil (India) Ltd | 3,741 Cr. | 82.5 | 111/78.0 | 24.8 | 22.0 | 0.61 % | 23.3 % | 17.6 % | 1.00 |
| DMCC Speciality Chemicals Ltd | 672 Cr. | 270 | 453/241 | 24.1 | 93.8 | 0.93 % | 14.1 % | 9.97 % | 10.0 |
| Industry Average | 12,917.28 Cr | 748.79 | 64.06 | 182.93 | 0.42% | 12.99% | 25.41% | 6.41 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 97.65 | 110.14 | 110.62 | 122.03 | 113.54 | 112.02 | 114.60 | 47.09 | 46.27 | 123.53 | 53.05 | 52.21 | 57.68 |
| Expenses | 96.66 | 100.93 | 99.46 | 108.81 | 104.59 | 97.51 | 100.44 | 44.01 | 42.83 | 110.87 | 49.27 | 48.61 | 54.21 |
| Operating Profit | 0.99 | 9.21 | 11.16 | 13.22 | 8.95 | 14.51 | 14.16 | 3.08 | 3.44 | 12.66 | 3.78 | 3.60 | 3.47 |
| OPM % | 1.01% | 8.36% | 10.09% | 10.83% | 7.88% | 12.95% | 12.36% | 6.54% | 7.43% | 10.25% | 7.13% | 6.90% | 6.02% |
| Other Income | 0.40 | 1.10 | 1.46 | 1.67 | 3.01 | 9.31 | 3.59 | 0.89 | 2.09 | 6.93 | 0.19 | 1.72 | 2.65 |
| Interest | 0.14 | 0.19 | 0.21 | 0.50 | 0.26 | 0.46 | 0.32 | 0.20 | 0.16 | 0.31 | 0.18 | 0.14 | 0.07 |
| Depreciation | 1.05 | 1.08 | 1.07 | 1.31 | 1.06 | 1.47 | 1.38 | 0.88 | 0.57 | 1.86 | 0.68 | 0.70 | 0.68 |
| Profit before tax | 0.20 | 9.04 | 11.34 | 13.08 | 10.64 | 21.89 | 16.05 | 2.89 | 4.80 | 17.42 | 3.11 | 4.48 | 5.37 |
| Tax % | 770.00% | 14.05% | 26.72% | 22.48% | 17.39% | 29.79% | 16.01% | 47.75% | 2.29% | 20.49% | -4.18% | 25.22% | 25.70% |
| Net Profit | -1.34 | 7.77 | 8.25 | 10.19 | 8.78 | 15.35 | 13.49 | 1.51 | 4.68 | 13.85 | 3.24 | 3.36 | 3.99 |
| EPS in Rs | -1.02 | 5.77 | 6.16 | 7.61 | 6.54 | 11.52 | 10.07 | 1.13 | 3.49 | 10.35 | 2.42 | 2.51 | 2.98 |
Last Updated: August 1, 2025, 10:45 pm
Below is a detailed analysis of the quarterly data for Chembond Chemicals Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 57.68 Cr.. The value appears strong and on an upward trend. It has increased from 52.21 Cr. (Mar 2025) to 57.68 Cr., marking an increase of 5.47 Cr..
- For Expenses, as of Jun 2025, the value is 54.21 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 48.61 Cr. (Mar 2025) to 54.21 Cr., marking an increase of 5.60 Cr..
- For Operating Profit, as of Jun 2025, the value is 3.47 Cr.. The value appears to be declining and may need further review. It has decreased from 3.60 Cr. (Mar 2025) to 3.47 Cr., marking a decrease of 0.13 Cr..
- For OPM %, as of Jun 2025, the value is 6.02%. The value appears to be declining and may need further review. It has decreased from 6.90% (Mar 2025) to 6.02%, marking a decrease of 0.88%.
- For Other Income, as of Jun 2025, the value is 2.65 Cr.. The value appears strong and on an upward trend. It has increased from 1.72 Cr. (Mar 2025) to 2.65 Cr., marking an increase of 0.93 Cr..
- For Interest, as of Jun 2025, the value is 0.07 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 0.14 Cr. (Mar 2025) to 0.07 Cr., marking a decrease of 0.07 Cr..
- For Depreciation, as of Jun 2025, the value is 0.68 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 0.70 Cr. (Mar 2025) to 0.68 Cr., marking a decrease of 0.02 Cr..
- For Profit before tax, as of Jun 2025, the value is 5.37 Cr.. The value appears strong and on an upward trend. It has increased from 4.48 Cr. (Mar 2025) to 5.37 Cr., marking an increase of 0.89 Cr..
- For Tax %, as of Jun 2025, the value is 25.70%. The value appears to be increasing, which may not be favorable. It has increased from 25.22% (Mar 2025) to 25.70%, marking an increase of 0.48%.
- For Net Profit, as of Jun 2025, the value is 3.99 Cr.. The value appears strong and on an upward trend. It has increased from 3.36 Cr. (Mar 2025) to 3.99 Cr., marking an increase of 0.63 Cr..
- For EPS in Rs, as of Jun 2025, the value is 2.98. The value appears strong and on an upward trend. It has increased from 2.51 (Mar 2025) to 2.98, marking an increase of 0.47.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: November 15, 2025, 5:34 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 274 | 299 | 270 | 291 | 327 | 301 | 268 | 274 | 349 | 440 | 178 | 201 | 221 |
| Expenses | 253 | 273 | 259 | 274 | 304 | 275 | 258 | 256 | 332 | 405 | 172 | 188 | 206 |
| Operating Profit | 21 | 26 | 11 | 17 | 23 | 26 | 10 | 18 | 17 | 35 | 7 | 14 | 15 |
| OPM % | 8% | 9% | 4% | 6% | 7% | 8% | 4% | 7% | 5% | 8% | 4% | 7% | 7% |
| Other Income | 1 | 1 | 189 | 18 | 11 | 4 | 3 | 15 | 9 | 5 | 14 | 9 | 5 |
| Interest | 4 | 4 | 2 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 0 |
| Depreciation | 3 | 4 | 4 | 4 | 4 | 4 | 4 | 5 | 4 | 5 | 3 | 3 | 3 |
| Profit before tax | 15 | 20 | 195 | 30 | 28 | 24 | 8 | 29 | 21 | 34 | 17 | 19 | 16 |
| Tax % | 40% | 28% | 20% | 24% | 16% | 19% | 61% | 28% | 32% | 26% | 33% | 10% | |
| Net Profit | 9 | 14 | 156 | 23 | 24 | 20 | 3 | 20 | 14 | 25 | 11 | 18 | 14 |
| EPS in Rs | 5.76 | 9.24 | 114.66 | 14.43 | 16.40 | 12.93 | 1.40 | 15.18 | 10.39 | 18.73 | 8.34 | 13.10 | 10.77 |
| Dividend Payout % | 26% | 16% | 4% | 11% | 11% | 16% | 144% | 15% | 48% | 16% | 42% | 13% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 55.56% | 1014.29% | -85.26% | 4.35% | -16.67% | -85.00% | 566.67% | -30.00% | 78.57% | -56.00% | 63.64% |
| Change in YoY Net Profit Growth (%) | 0.00% | 958.73% | -1099.54% | 89.60% | -21.01% | -68.33% | 651.67% | -596.67% | 108.57% | -134.57% | 119.64% |
Chembond Chemicals Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | -4% |
| 5 Years: | -6% |
| 3 Years: | -17% |
| TTM: | -10% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 2% |
| 5 Years: | 54% |
| 3 Years: | 4% |
| TTM: | -34% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 2% |
| 5 Years: | 8% |
| 3 Years: | 7% |
| 1 Year: | -62% |
| Return on Equity | |
|---|---|
| 10 Years: | 7% |
| 5 Years: | 6% |
| 3 Years: | 7% |
| Last Year: | 10% |
Last Updated: September 5, 2025, 1:50 am
Balance Sheet
Last Updated: November 9, 2025, 1:50 pm
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 |
| Reserves | 80 | 89 | 200 | 223 | 242 | 255 | 262 | 286 | 297 | 315 | 137 | 149 | 155 |
| Borrowings | 33 | 25 | 11 | 9 | 9 | 7 | 3 | 2 | 2 | 7 | 7 | 3 | 6 |
| Other Liabilities | 86 | 83 | 72 | 82 | 68 | 54 | 50 | 59 | 56 | 74 | 41 | 43 | 44 |
| Total Liabilities | 205 | 203 | 289 | 321 | 325 | 322 | 322 | 354 | 361 | 402 | 191 | 202 | 211 |
| Fixed Assets | 54 | 51 | 47 | 49 | 108 | 109 | 124 | 122 | 121 | 116 | 26 | 34 | 41 |
| CWIP | 3 | 3 | 2 | 2 | 1 | 2 | 0 | 0 | 1 | 12 | 13 | 8 | 1 |
| Investments | 1 | 1 | 88 | 150 | 76 | 58 | 51 | 73 | 75 | 65 | 65 | 78 | 68 |
| Other Assets | 148 | 147 | 152 | 120 | 140 | 153 | 147 | 160 | 165 | 208 | 87 | 83 | 101 |
| Total Assets | 205 | 203 | 289 | 321 | 325 | 322 | 322 | 354 | 361 | 402 | 191 | 202 | 211 |
Below is a detailed analysis of the balance sheet data for Chembond Chemicals Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 7.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 7.00 Cr..
- For Reserves, as of Sep 2025, the value is 155.00 Cr.. The value appears strong and on an upward trend. It has increased from 149.00 Cr. (Mar 2025) to 155.00 Cr., marking an increase of 6.00 Cr..
- For Borrowings, as of Sep 2025, the value is 6.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 3.00 Cr. (Mar 2025) to 6.00 Cr., marking an increase of 3.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 44.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 43.00 Cr. (Mar 2025) to 44.00 Cr., marking an increase of 1.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 211.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 202.00 Cr. (Mar 2025) to 211.00 Cr., marking an increase of 9.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 41.00 Cr.. The value appears strong and on an upward trend. It has increased from 34.00 Cr. (Mar 2025) to 41.00 Cr., marking an increase of 7.00 Cr..
- For CWIP, as of Sep 2025, the value is 1.00 Cr.. The value appears to be declining and may need further review. It has decreased from 8.00 Cr. (Mar 2025) to 1.00 Cr., marking a decrease of 7.00 Cr..
- For Investments, as of Sep 2025, the value is 68.00 Cr.. The value appears to be declining and may need further review. It has decreased from 78.00 Cr. (Mar 2025) to 68.00 Cr., marking a decrease of 10.00 Cr..
- For Other Assets, as of Sep 2025, the value is 101.00 Cr.. The value appears strong and on an upward trend. It has increased from 83.00 Cr. (Mar 2025) to 101.00 Cr., marking an increase of 18.00 Cr..
- For Total Assets, as of Sep 2025, the value is 211.00 Cr.. The value appears strong and on an upward trend. It has increased from 202.00 Cr. (Mar 2025) to 211.00 Cr., marking an increase of 9.00 Cr..
Notably, the Reserves (155.00 Cr.) exceed the Borrowings (6.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow - No data available for this post.
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -12.00 | 1.00 | 0.00 | 8.00 | 14.00 | 19.00 | 7.00 | 16.00 | 15.00 | 28.00 | 0.00 | 11.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 116 | 105 | 78 | 84 | 90 | 110 | 112 | 111 | 94 | 96 | 100 | 72 |
| Inventory Days | 74 | 60 | 46 | 59 | 46 | 58 | 77 | 82 | 67 | 53 | 58 | 56 |
| Days Payable | 113 | 96 | 86 | 95 | 96 | 84 | 96 | 120 | 76 | 81 | 118 | 113 |
| Cash Conversion Cycle | 77 | 70 | 38 | 49 | 40 | 84 | 94 | 73 | 84 | 67 | 40 | 15 |
| Working Capital Days | 53 | 45 | 90 | 42 | 44 | 82 | 98 | 83 | 78 | 70 | 39 | 25 |
| ROCE % | 15% | 18% | 22% | 12% | 11% | 9% | 3% | 10% | 7% | 10% | 5% | 12% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 |
|---|---|---|
| FaceValue | 5.00 | 5.00 |
| Basic EPS (Rs.) | 11.54 | 11.20 |
| Diluted EPS (Rs.) | 11.54 | 11.20 |
| Cash EPS (Rs.) | 13.33 | 12.13 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 64.77 | 53.13 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 64.77 | 53.13 |
| Revenue From Operations / Share (Rs.) | 108.67 | 105.31 |
| PBDIT / Share (Rs.) | 17.76 | 16.97 |
| PBIT / Share (Rs.) | 15.93 | 16.00 |
| PBT / Share (Rs.) | 15.68 | 15.78 |
| Net Profit / Share (Rs.) | 11.49 | 11.16 |
| NP After MI And SOA / Share (Rs.) | 11.54 | 11.20 |
| PBDIT Margin (%) | 16.34 | 16.11 |
| PBIT Margin (%) | 14.65 | 15.19 |
| PBT Margin (%) | 14.42 | 14.98 |
| Net Profit Margin (%) | 10.57 | 10.59 |
| NP After MI And SOA Margin (%) | 10.62 | 10.63 |
| Return on Networth / Equity (%) | 17.81 | 21.07 |
| Return on Capital Employeed (%) | 24.05 | 29.22 |
| Return On Assets (%) | 14.36 | 16.50 |
| Asset Turnover Ratio (%) | 1.47 | 0.00 |
| Current Ratio (X) | 4.81 | 4.32 |
| Quick Ratio (X) | 4.33 | 3.83 |
| Inventory Turnover Ratio (X) | 16.42 | 0.00 |
| Interest Coverage Ratio (X) | 71.55 | 76.92 |
| Interest Coverage Ratio (Post Tax) (X) | 47.31 | 51.58 |
After reviewing the key financial ratios for Chembond Chemicals Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 5.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 5.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 11.54. This value is within the healthy range. It has increased from 11.20 (Mar 24) to 11.54, marking an increase of 0.34.
- For Diluted EPS (Rs.), as of Mar 25, the value is 11.54. This value is within the healthy range. It has increased from 11.20 (Mar 24) to 11.54, marking an increase of 0.34.
- For Cash EPS (Rs.), as of Mar 25, the value is 13.33. This value is within the healthy range. It has increased from 12.13 (Mar 24) to 13.33, marking an increase of 1.20.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 64.77. It has increased from 53.13 (Mar 24) to 64.77, marking an increase of 11.64.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 64.77. It has increased from 53.13 (Mar 24) to 64.77, marking an increase of 11.64.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 108.67. It has increased from 105.31 (Mar 24) to 108.67, marking an increase of 3.36.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 17.76. This value is within the healthy range. It has increased from 16.97 (Mar 24) to 17.76, marking an increase of 0.79.
- For PBIT / Share (Rs.), as of Mar 25, the value is 15.93. This value is within the healthy range. It has decreased from 16.00 (Mar 24) to 15.93, marking a decrease of 0.07.
- For PBT / Share (Rs.), as of Mar 25, the value is 15.68. This value is within the healthy range. It has decreased from 15.78 (Mar 24) to 15.68, marking a decrease of 0.10.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 11.49. This value is within the healthy range. It has increased from 11.16 (Mar 24) to 11.49, marking an increase of 0.33.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 11.54. This value is within the healthy range. It has increased from 11.20 (Mar 24) to 11.54, marking an increase of 0.34.
- For PBDIT Margin (%), as of Mar 25, the value is 16.34. This value is within the healthy range. It has increased from 16.11 (Mar 24) to 16.34, marking an increase of 0.23.
- For PBIT Margin (%), as of Mar 25, the value is 14.65. This value is within the healthy range. It has decreased from 15.19 (Mar 24) to 14.65, marking a decrease of 0.54.
- For PBT Margin (%), as of Mar 25, the value is 14.42. This value is within the healthy range. It has decreased from 14.98 (Mar 24) to 14.42, marking a decrease of 0.56.
- For Net Profit Margin (%), as of Mar 25, the value is 10.57. This value exceeds the healthy maximum of 10. It has decreased from 10.59 (Mar 24) to 10.57, marking a decrease of 0.02.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 10.62. This value is within the healthy range. It has decreased from 10.63 (Mar 24) to 10.62, marking a decrease of 0.01.
- For Return on Networth / Equity (%), as of Mar 25, the value is 17.81. This value is within the healthy range. It has decreased from 21.07 (Mar 24) to 17.81, marking a decrease of 3.26.
- For Return on Capital Employeed (%), as of Mar 25, the value is 24.05. This value is within the healthy range. It has decreased from 29.22 (Mar 24) to 24.05, marking a decrease of 5.17.
- For Return On Assets (%), as of Mar 25, the value is 14.36. This value is within the healthy range. It has decreased from 16.50 (Mar 24) to 14.36, marking a decrease of 2.14.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 1.47. It has increased from 0.00 (Mar 24) to 1.47, marking an increase of 1.47.
- For Current Ratio (X), as of Mar 25, the value is 4.81. This value exceeds the healthy maximum of 3. It has increased from 4.32 (Mar 24) to 4.81, marking an increase of 0.49.
- For Quick Ratio (X), as of Mar 25, the value is 4.33. This value exceeds the healthy maximum of 2. It has increased from 3.83 (Mar 24) to 4.33, marking an increase of 0.50.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 16.42. This value exceeds the healthy maximum of 8. It has increased from 0.00 (Mar 24) to 16.42, marking an increase of 16.42.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 71.55. This value is within the healthy range. It has decreased from 76.92 (Mar 24) to 71.55, marking a decrease of 5.37.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 47.31. This value is within the healthy range. It has decreased from 51.58 (Mar 24) to 47.31, marking a decrease of 4.27.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Chembond Chemicals Ltd:
- Net Profit Margin: 10.57%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 24.05% (Industry Average ROCE: 12.99%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 17.81% (Industry Average ROE: 24.61%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 47.31
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 4.33
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 15.6 (Industry average Stock P/E: 56.06)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 10.57%
Fundamental Analysis of Chembond Chemicals Ltd
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Chemicals - Speciality - Others | Chembond Centre, EL71, MIDC Mahape, New Mumbai Maharashtra 400710 | info@chembondindia.com http://www.chembondindia.com |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Sameer V Shah | Chairman & Managing Director |
| Mr. Nirmal V Shah | Vice Chairperson & M.D |
| Mr. Ashwin R Nagarwadia | Non Executive Director |
| Mr. Mahendra K Ghelani | Independent Director |
| Dr. Prakash D Trivedi | Independent Director |
| Mrs. Saraswati Sankar | Independent Director |
| Mr. Sushil U Lakhani | Independent Director |
Chembond Chemicals Ltd. Share Price Update | |
|---|---|
| Share Price | Value |
| Today | ₹579.50 |
| Previous Day | ₹586.75 |
FAQ
What is the intrinsic value of Chembond Chemicals Ltd?
Chembond Chemicals Ltd's intrinsic value (as of 20 November 2025) is 160.21 which is 4.64% lower the current market price of 168.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 225 Cr. market cap, FY2025-2026 high/low of 490/159, reserves of ₹155 Cr, and liabilities of 211 Cr.
What is the Market Cap of Chembond Chemicals Ltd?
The Market Cap of Chembond Chemicals Ltd is 225 Cr..
What is the current Stock Price of Chembond Chemicals Ltd as on 20 November 2025?
The current stock price of Chembond Chemicals Ltd as on 20 November 2025 is 168.
What is the High / Low of Chembond Chemicals Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Chembond Chemicals Ltd stocks is 490/159.
What is the Stock P/E of Chembond Chemicals Ltd?
The Stock P/E of Chembond Chemicals Ltd is 15.6.
What is the Book Value of Chembond Chemicals Ltd?
The Book Value of Chembond Chemicals Ltd is 121.
What is the Dividend Yield of Chembond Chemicals Ltd?
The Dividend Yield of Chembond Chemicals Ltd is 1.04 %.
What is the ROCE of Chembond Chemicals Ltd?
The ROCE of Chembond Chemicals Ltd is 11.5 %.
What is the ROE of Chembond Chemicals Ltd?
The ROE of Chembond Chemicals Ltd is 10.5 %.
What is the Face Value of Chembond Chemicals Ltd?
The Face Value of Chembond Chemicals Ltd is 5.00.